If the relevant Director decides to suspend an approved arrangement, or a part of an approved arrangement, under subsection 418(1), the Director must give the biosecurity industry participant covered by the arrangement written notice stating that the arrangement, or the part of the arrangement, is suspended for the period specified in the notice.